From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Past Events

Facing vaccine doubts, US grapples with building confidence in coronavirus shots - BioPharma Dive
Dive Brief: The Centers for Disease Control and Prevention does not back mandates that healthcare workers or other essential employees receive COVID-19 vaccines, with a CDC official stating Thursday the ag
US faces major hurdles for COVID-19 vaccine distribution: Vaccine advisory committee - MSN
Any coronavirus vaccine that could be authorized for emergency use by the U.S. Food and Drug Administration (FDA) faces several additional hurdles after completing the final stage of clinical trials.
FDA Panel Stresses Safety, Diversity, Efficacy for COVID-19 Vax - MedPage Today
COVID-19 vaccine safety, dueling efficacy standards, and representation of groups from racial and ethnic minorities to children drew focus Thursday at arguably the most watched FDA advisory committee meeting ever.
CDC distribution roadmap, safety oversight plans, and other takeaways from FDA’s big COVID-19 vaccine meeting - ExBulletin
In less than a year, scientists around the world have rallied against COVID-19 and developed promising vaccines that could stem the pandemic.
Group Of Independent Experts To Advise FDA On Coronavirus Vaccine Approval - WUWM Milwaukee
It's up to the Food and Drug Administration to decide whether a COVID-19 vaccine is safe and effective enough for public distribution.
In historic Covid-19 adcomm, vaccine experts debate a sea of questions — but offer no clear answers - Endpoints News
The most widely anticipated and perhaps most widely watched meeting in the FDA’s 113-year history ended late Thursday night with a score of questions and very few answers.
Confidence still lacking in future COVID-19 vaccines - BioWorld
With the lack of public trust and confidence the biggest barrier to SARS-CoV-2 vaccines in the U.S., the risk of granting an emergency use authorization (EUA) to a vaccine with safety issues or questionable efficacy could
Core Concept: The pandemic is prompting widespread use—and misuse—of real-world data - PNAS
COVID-19 has swept across the world, overwhelming healthcare systems and raising countless questions about how best to diagnose patients, treat infections, save lives, and contain the pandemic.
FDA study finds fear and distrust among front-line workers and minority groups around COVID-19 vaccines - Fierce Pharma
Powerful, illuminating and sobering—that’s the description from a research group summing up its initial listening sessions with front-line workers and minority groups about a vaccine.
What to expect from the official COVID-19 vaccine committee - ABC News
As the race for an effective COVID-19 vaccine continues, the public will get inside look at one a crucial part of the Food and Drug Administration's decisio